SHARE PRICE QUOTE:
Day High: • Day Low:
Volume:

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Stephen H. Wise

    Stephen H. Wise
    Co-Head of Americas Corporate Private Equity
    Stephen H. Wise is a Partner and Co-Head of Americas Corporate Private Equity at Carlyle. He is based in New York. Since joining Carlyle in 2006, Carlyle’s Healthcare team has invested nearly $20 billion of equity in healthcare companies around the world. Mr. Wise has led or been a key contributor to several Carlyle investments including CorroHealth, a business service provider for healthcare companies, Curia, a contract research and drug manufacturing organization, Medline, a leading global branded medical products manufacturer with a wholly-owned vertically integrated distribution network, MedRisk, a physical therapy-focused workers’ compensation solutions company, Millicent Pharma, a pharmaceutical company, MultiPlan, a scaled independent preferred provider organization, QuidelOrtho, a global provider of in vitro diagnostic solutions for screening, diagnosing, monitoring and confirming diseases, Pharmaceutical Product Development (PPD), a global contract research organization, Rede D’Or São Luiz, a hospital provider in Brazil, Resonetics, a leading contract development and manufacturing organization specializing in complex micro-manufacturing of components for medical device original equipment manufacturers, Sedgwick, a global multiline claims management firm, TriNetX, a global health research network optimizing clinical research, Unchained Labs, a global life science tools company, and WellDyneRx, an independent pharmacy benefit manager. Mr. Wise also led Carlyle’s broader life sciences efforts, including the acquisition of Abingworth. Prior to joining Carlyle, Mr. Wise worked with JLL Partners, a New York-based private equity firm, where he focused on health care-related investments. Previously, he worked with J.W. Childs Associates, a Boston-based private equity firm, and prior to that, in the leveraged finance group of Credit Suisse. Mr. Wise serves as a director on the boards of Curia, Launch Therapeutics, Medline, Resonetics, and Sedgwick. Mr. Wise also serves on the advisory board for the Massachusetts General Hospital Center for Global Health. Mr. Wise earned a bachelor’s degree in economics and finance from Bucknell University and received his master’s in business administration from Harvard Business School.

    Michael Wand

      Michael Wand
      Head of Europe Private Equity
      Michael Wand is Head of Europe Private Equity where he oversees the firm’s Corporate Private Equity platform in the region: Carlyle Europe Technology Partners and Carlyle Europe Partners. He is based in London. Mr. Wand has led numerous technology investments, notably P&I AG, FRS Global, UC4/Automic, Foundry, eggplant and Dept, and advised on a dozen completed realizations. Mr. Wand is currently a member of the Boards of Directors of Shopware, SER Group, HSO, Dept, Jagex, Disguise, LiveU and Incubeta. In addition, Mr. Wand is Co-Head of Europe Private Equity, sitting on Carlyle’s European Private Equity Executive Committee which was formed in 2022 to drive deeper collaboration across all the firm’s Corporate Private Equity activities in the region. Prior to joining Carlyle in 2001, Mr. Wand worked for approximately 10 years in investment banking, the last seven years of which were in the technology sector. As a Managing Director, he was responsible for the European software and Internet research team at Deutsche Bank in London. Prior to that, he worked as a European Software Analyst for Paribas in London and BHF-Bank in Frankfurt, Germany. During his banking career, Mr. Wand was the underwriting analyst for European technology innovators such as SAP, Autonomy, SurfControl, Utimaco and nCipher.

      Afsaneh Beschloss

        Afsaneh Beschloss
        Founder and Chief Executive Officer of RockCreek

        Ms. Beschloss was appointed to our Board of Directors effective May 1, 2024. Ms. Beschloss is an economist, a leader in sustainable and inclusive investing and policy, and founder and CEO of RockCreek, one of the world’s largest women-owned investment firms. Previously, she was Managing Director and partner at The Carlyle Group from 2001 to 2003. As the World Bank’s Treasurer and Chief Investment Officer, she led the Bank’s investments, balance sheet management, ratings, borrowings, and innovations in financial products and in technology. Prior to this, she led the World Bank’s investments and policy work in the renewable energy, power, and infrastructure sectors, notably pioneering investments in natural gas, wind, and solar energy. Previously, she worked in corporate finance at JP Morgan. Ms. Beschloss has advised various governments, central banks, and regulatory agencies on financial policy and energy policy. She serves on the boards of trustees of the Council on Foreign Relations, the Rockefeller Foundation, where she chairs the Investment Committee, the Bretton Woods Committee, where she co-chairs the Future of Finance Working Group, Georgetown University, and the PBS Foundation where she serves as chair. She was recognized by Carnegie Corporation in their “Great Immigrants, Great Americans 2020” list, received the Robert F. Kennedy Human Rights Ripple of Hope Award and the Institutional Investor Lifetime Achievement Award, and has been listed among the “Most Powerful Women in Banking” by American Banker. She is the co-author of The Economics of Natural Gas (Oxford University Press) and author of numerous journal articles on innovations in finance, energy economics, and renewable energy investing. Ms. Beschloss holds an MPhil (Honors) in Economics from the University of Oxford, where she taught international trade and economic development.

        Lindsay LoBue

          Lindsay LoBue
          Deputy Chief Operating Officer

          Lindsay LoBue will become the Chief Operating Officer of Carlyle, effective July 1, 2024. She is based in New York. Ms. LoBue is a member of Carlyle’s Leadership and Operating Committees. She currently is Deputy COO of Carlyle. Prior to that, Ms. LoBue spent over 20 years at Goldman Sachs, most recently as an Advisory Director working across global divisions on strategic growth initiatives. Before that, Ms. LoBue was a Partner in the Global Markets division, responsible for leading and managing client-facing businesses in a variety of areas. She managed the firm’s Investment Grade Corporate Bond sales team, expanding their cross-product distribution. In addition, she founded the Credit Products Group, a solutions business for illiquid and esoteric risk, and led the growth of the firm’s Structured Products, Relative Value and Solutions, and Credit Derivatives franchise efforts, capitalizing on evolving market opportunities. Prior to joining Goldman Sachs, Ms. LoBue was a Structured Products Salesperson and CMBS Research Analyst at J.P. Morgan. Ms. LoBue was also the founder of Greenback Labs, a platform that focused on advancing emerging ideas and businesses by working with entrepreneurs to validate business ideas and execute growth strategies. Ms. LoBue is a Board Member of Enel Finance Americas, the financing arm within the Enel Group, and she is a member of the Board of Regents at Boston College. Ms. LoBue has an MBA in Finance and Marketing from NYU, and a Bachelor of Science in Marketing and Psychology from Boston College.

          Subscribe to